Delivery Order SPE2DB22D3501-SPE2DB25FVY68
Award Date
6/6/25
Potential Completion Date
6/9/25
Potential Value
$2.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PROLENSA 0.07% eye drops, a prescription medication, with a ceiling value of $1,950.80 and a period of performance through May 9, 2025. The contract is not set aside and appears to be part of a larger Indefinite Delivery Contract (IDC) vehicle, designated as SPE2DX, which has a...
This federal contract award was made by the Medical Supply Chain division of the U.S. Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of PROLENSA 0.07% eye drops. The contract has a ceiling value of $1,025.79 and is a Firm Fixed Price Delivery Order with a completion date of July 11, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00...
This federal contract award is from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of 4,555,355,594 units of PROLENSA 0.07% eye drops in 3 milliliter vials. The firm-fixed-price delivery order, valued at $16,328.27, has a period of performance through November 9, 2021. This award is not designated as a set-aside contract. The contract is part of a larger Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of PROLENSA 0.07% eye drops, a specialty pharmaceutical product, with a ceiling value of $1,261.70. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is October 11, 2023. The contract award is not associated with...
The federal contract award is for the delivery of PROLENSA 0.07% eye drops, 3ml, to the Defense Logistics Agency (DLA). The $2,031.44 fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on July 12, 2024, with a completion date of July 15, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,560,258,236 units of PROLENSA 0.07% eye drops. The Firm Fixed Price delivery order, valued at $4,319.98, has a period of performance through March 15, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $2,487.42 firm fixed-price contract is for the delivery of PROLENSA 0.07% eye drops, with a completion date of January 17, 2023. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the delivery of PROLENSA 0.07% eye drops in a 3 ML size. The contract has a ceiling value of $1,211.31 and a completion date of May 21, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of PROLENSA 0.07% eye drops (3 mL). The $1,777.03 firm fixed-price delivery order does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range of...
This federal contract award is for the delivery of PROLENSA 0.07% eye drops (3ml) to the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense (DoD). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., on September 26, 2023, with a total ceiling value of $19,398.20 and a completion date of September 27, 2023. The contract is a delivery order with a firm fixed-price pricing type. This contract is not...